SOPHiA GENETICS SA
SOPHNASDAQHealthcareHealth Information Services
As of Oct 22, 2026 close
- Market cap
- $520.56M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.75$8.98
- Volume (live)
- -
- Avg. volume (3M)
- 688.18K
SOPHiA GENETICS SA (SOPH) Stock Price & Financial Analysis
SOPHiA GENETICS SA Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.97 - $7.38 |
|---|---|
| 52-Week High | $8.98 |
| 52-Week Low | $3.75 |
| Open | $7.27 |
| Volume (last close) | 353.20K |
| Average Volume (3M) | 688.18K |
| Revenue (TTM) | 86.17M |
|---|---|
| Net Income (TTM) | -80.88M |
| Free Cash Flow (TTM) | -43.08M |
| EPS (TTM) | −$1.15 |
| Profit Margin | -93.86% |
| Operating Margin | -85.55% |
| Return on Equity (ROE) | -97.31% |
| Debt to Equity | 0.61 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 520.56M |
|---|---|
| Shares Outstanding | 73.84M |
| Price to Sales (P/S) | 6.04 |
| Price to Book (P/B) | 6.26 |
| EV/EBITDA | -7.05 |
| 50-Day MA | $7.91 |
|---|---|
| 200-Day MA | $5.85 |
| 1-Year Change | +71.12% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
SOPHiA GENETICS SA at a Glance
As of the Oct 22, 2026 close, SOPHiA GENETICS SA (SOPH) has a market capitalization of $520.56M. The stock trades at 6.0× sales. Over the trailing twelve months it lost $80.88M on revenue of $86.17M and burned $43.08M of free cash flow. Revenue grew 23.6% year over year.
As of its latest reported balance sheet, it holds $107.67M in cash and securities against $50.72M of debt, a net cash position of $56.95M.
SOPHiA GENETICS SA does not currently pay a dividend.
The share price is up 71.1% over the past year. At $7.05 (the Oct 22, 2026 close) it sits within its 52-week range of $3.75 to $8.98, above its 200-day moving average of $5.85.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $10.00, 41.8% above the Oct 22, 2026 close.
Frequently Asked Questions About SOPHiA GENETICS SA
What is the current stock price for SOPH?
As of the Oct 22, 2026 close, SOPH stock trades at $7.05. The 52-week range is $3.75–$8.98, with a day range of $6.97–$7.38.
What is the P/E ratio for SOPH?
The P/E ratio (Price-to-Earnings) for SOPH is shown in the Key Statistics section. This valuation metric helps compare SOPHiA GENETICS SA to industry peers.
Does SOPH pay dividends?
SOPHiA GENETICS SA does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SOPH?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for SOPH is Buy. The average 12-month price target is $10.00, a 41.8% upside from the Oct 22, 2026 close of $7.05.
What is the market cap of SOPH?
As of the Oct 22, 2026 close, SOPHiA GENETICS SA's market capitalization is $520.6M, classifying it as a small-cap company. SOPHiA GENETICS SA operates in the Healthcare sector within the Health Information Services industry.